Scope Law advises the Swiss team of a fast-growing international specialty pharma company in in/out-licensing and IP-transfer agreement negotiations to develop, commercialize and distribute an innovative pharmaceutical products together with partners such as venture capital funds.
top of page
Recent Posts
See AllScope Law advises ETFbook , Zurich, in its EUR 4 million Series A financing round, led by BlackFin Capital Partners BlackFin Capital...
Scope Law advises qCella AG , Zurich, a spin-off of ETH Zurich in its CHF 1.3 million pre-seed financing round. Participating investors...
Scope Law acts as Swiss legal counsel to the sole shareholder and managing director of NCD Ingredients GmbH (Germany) on the sale of all...
bottom of page
Comments